California-based company unveils ‘smart’ ring for women

The US healthcare company Movano Health has announced a new wearable to help women track and monitor their health.

According to the developers, the smart ring is an intelligent device that provide users with medical grade health data translated into personalised insights on an app.

Evie combines health and wellness metrics and aims to give women a full picture of their health, monitoring and tracking resting heart rate, heart rate variability, SpO₂, respiration rate, skin temperature variability, period and ovulation, menstrual symptoms as well as activity and mood.

The company says the app simplifies findings and turns biometric data into actionable insights to help women make manageable lifestyle changes and take a more proactive approach to mitigating the risks of chronic disease.

“As a medical device, Evie will go beyond the status quo of other wearables on the market, and we believe it has the power to transform women’s lives and overall health,” said Dr John Mastrototaro, CEO of Movano Health.

“We are bringing together medical grade biometric data and insights in a comfortable and contemporary wearable that allows women to take ownership of their unique health journey.”

In December, Movano announced successful preliminary results of its hypoxia trial to assess the accuracy of the smart ring’s blood oxygen saturation (SpO₂) and heart rate data.

Now, the company plans to file for FDA clearance of Evie and make it the first consumer wearable that is also approved as a medical device.

“We are deeply committed to developing wearable devices that go beyond the status quo and give all consumers, regardless of gender and ethnicity, a higher level of confidence and trust in their health data,” Mastrototaro added. 

“Clearance of a wearable device requires extensive investment in research and development, and it has been a central goal of ours since the beginning. Providing medical-grade heart rate and SpO₂ data in the future will position us to help users better predict, prevent and understand health issues.

“FDA approval remains one of the top priorities for our smart ring and the outstanding preliminary results we received from our pivotal study are extremely exciting.”

Evie will be unveiled during the Consumer Electronics Show (CES) 2023 alongside a demo showcasing its features.

The ring, expected to cost around US$300, will be launching this year and it will be available in sizes 5-11.